BioCentury
ARTICLE | Financial News

Infinity financial update

April 22, 2013 7:00 AM UTC

Investors Beacon and Rosebay Medical sold 1.4 million shares at $40 to cover the overallotment from an April 11 secondary offering, bringing the total sold to $456.7 million. The investors no longer have a stake in Infinity. Beacon and Rosebay are associated companies of Purdue Pharma L.P. (Stamford, Conn.), which transferred a portion of its shares to the investors. Infinity, which closed Friday at $40.76, has 47.8 million shares outstanding. ...